Intec Pharma Ltd buy stratec
Start price
16.08.18
/
50%
?3.70
Target price
31.07.19
€9.92
Performance (%)
-89.33%
End price
31.07.19
€0.39
Summary
This prediction ended on 31.07.19 with a price of €0.39. Massive losses of -89.33% were the result for the BUY prediction by stratec. stratec has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m | 1y | 3y |
|---|---|---|---|---|
| Intec Pharma Ltd | - | - | - | - |
| iShares Core DAX® | 1.085% | -0.846% | 12.464% | 58.472% |
| iShares Nasdaq 100 | -1.665% | -3.306% | 1.502% | 84.473% |
| iShares Nikkei 225® | 3.863% | 6.308% | 22.272% | 56.185% |
| iShares S&P 500 | 0.111% | -1.337% | 1.101% | 58.320% |
Comments by stratec for this prediction
In the thread Intec Pharma Ltd diskutieren
stratec stimmt der Buy-Einschätzung von tamam zu
stratec stimmt am 16.08.2018 der Buy-Einschätzung von tamam mit dem Kursziel 5,2$ zu.
Überschrift: Intec , a good time to go ¨bottom-fishing¨
Intec reported 2Q18 with a net loss of $11M and ended the quarter with $66.2M in cash on the balance sheet, sufficient runway at the current burn rate into 2H19 and through the pivotal P3 data for Accordion Pill (NYSE:AP)) in Parkinson’s Disease.
(Vom Mitglied beendet)